Adeptus Health (ADPT) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Jefferies Cuts Price Target on Adeptus Health (ADPT) Following 2Q Report; Reiterates Buy
July 22, 2016 8:54 AM EDTJefferies maintained a Buy rating on Adeptus Health (NYSE: ADPT), and cut the price target to $100.00 (from $113.00), following the company's 2Q earnings report. Q2 results mostly came in below expectations and at the low end of management's guidance. Jefferies does not expect meaningful... More
